Recent progress on fucosyltransferase inhibitors.

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Glycobiology

Background:

• Fucosyltransferases (FucTs) catalyze the transfer of L-fucose, a crucial modification in biological processes.
• Dysregulation of FucTs is implicated in various pathologies, including cancer, autoimmune disorders, infections, and inflammation.
• FucTs are recognized as significant therapeutic targets for drug development.

Purpose of the Study:

• To review recent advancements in the development of carbohydrate mimics as FucT inhibitors.
• To highlight the latest synthetic methodologies for creating these inhibitors.
• To provide insights into potential therapeutic applications targeting FucT enzymes.

Main Methods:

• Literature review focusing on recent publications related to FucT inhibitors and carbohydrate mimics.
• Analysis of synthetic strategies employed in the design and preparation of FucT inhibitors.
• Evaluation of the therapeutic potential of identified carbohydrate mimics.

Main Results:

• Several classes of carbohydrate mimics have emerged as potent FucT inhibitors.
• Innovative synthetic routes have been developed for efficient production of these mimics.
• These inhibitors show promise for treating FucT-associated diseases.

Conclusions:

• Carbohydrate mimics represent a promising class of FucT inhibitors.
• Continued research into their synthesis and biological activity could lead to novel therapeutics.
• Targeting FucTs with these mimics offers a viable strategy for disease intervention.